Clinical Trial Update: Directed Topical Drug Delivery for Treatment for PASC Hyposmia [Phase 2]

View source ↗

Summary

Phase 2 trial update on directed topical drug delivery for hyposmia associated with post-acute sequelae of SARS-CoV-2 infection. The study has completed and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyposmia
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Duke University | Conditions: Post Acute Sequelae Covid-19 Hyposmia | Phase 2 | Status: COMPLETED | Results posted: 2026-03-19